Beware the PINK-SNO man — the secret cause of Parkinson's disease
Scientists from The Scripps Research Institute (TSRI) have shown how a process in nerve cells called the S-nitrosylation (SNO) reaction may contribute to Parkinson’s disease.
Their work shows how the SNO reaction attaches a nitric oxide-like molecule to protein called PINK1, where the molecule attaches to a building block on PINK1 called a cysteine residue. This changes PINK1’s activity — and its ability to do its job.
Since the SNO reaction was co-discovered by TSRI Professor Stuart Lipton and his group some 20 years ago, scientists have linked the reaction to protein misfolding and nerve cell damage in cases of Alzheimer’s, Huntington’s, amyotrophic lateral sclerosis (ALS) and Parkinson’s disease, as well as heart/cardiovascular disease and cancer. In the new study, Professor Lipton and his colleagues used human stem cell and mouse models to show exactly how SNO can trigger cell death in Parkinson’s disease.
Writing in the journal Cells Reports, the researchers revealed that when SNO modifies PINK1, nerve cells cannot recruit another protein called Parkin to get rid of damaged mitochondria — the energy powerhouses of the cell. Because neurons need a lot of energy, Professor Lipton said, it is especially crucial for them to use only healthy mitochondria and get rid of the damaged ones.
Mitochondria can be damaged as people age and cells experience various forms of stress, and it is the job of PINK1 to help trigger a process called mitophagy to remove those dysfunctional mitochondria. Previous studies had shown that inherited mutations to the gene that codes for PINK1 can stop a person from making working versions of the protein. This means their neurons cannot clear damaged mitochondria, and those cells eventually die — which can cause Parkinson’s.
The SNO reaction seems to cause this same problem, but it is not inherited. Instead, cells start ‘SNO-ing’ proteins when they get overwhelmed by reactive nitrogen molecules.
“The quantities of these reactive chemical species get so high that cells start SNO-ing proteins, like PINK1, that would normally not be SNO-ed,” said Professor Lipton. The researchers call this the PINK-SNO complex, or a ‘PINK-SNO man’.
“Formation of PINK-SNO is definitely harmful to nerve cells in the Parkinson’s brain,” said Professor Lipton.
So where are these reactive nitrogen species coming from? The scientists said cells can generate excessive nitric oxide in response to pesticide exposure, other toxins and possibly even air pollution. Professor Lipton admitted this is “a scary thought, but also a hopeful thought”, noting, “If we can figure out how we’re doing this to ourselves, we may be able to control it.”
The study adds to the evidence that some degenerative brain diseases appear to be caused by a combination of genetics and environment, with Professor Lipton stating that genetics may leave some people ‘predisposed’ to be at risk for SNO-related Parkinson’s. Because humans inherit two copies (one from each parent) of the gene that encodes PINK1, we all have at least one copy of the gene if the other is mutated. Depending on the protein, this may or may not be sufficient for normal function.
“But, in any event, if the protein translated from the remaining good copy of the gene is then targeted by SNO, then you are stuck making dysfunctional PINK1 even from the remaining good copy of the gene,” said Professor Lipton. “The take-home message here is that the environment may affect you based on your individual genetics, and thus both are influential in causing diseases like Parkinson’s.”
Interestingly, Professor Lipton’s team found that SNO-ing appears to occur early in disease progression — early enough that intervention may be able to save brain function. He said the next step is to study how to prevent these aberrant SNO reactions on particular proteins like PINK1, particularly through the use of new pharmaceuticals.
While scientists have thought that individual cell lines remain genetically uniform, they can in...
A novel peptide drug called FFW could potentially stop the development of hepatocellular...
Industry and academia are coming together in a three-year, $6.9 million quest to search for new...